Rational design of integrated nanocatalysts with hollow mesoporous transition metal silicates for chemoselective hydrogenation of cinnamaldehyde

Semi-hydrogenation of α,β-unsaturated aldehydes over sandwich-structured nanocatalysts prepared by phase transformation of thin-film Al2O3 to Al-TCPP

The semi-hydrogenation of α,β-unsaturated aldehydes to the desired unsaturated alcohols with both high conversion and high selectivity remains a big challenge. Herein, we designed a sandwich-structured nanocatalyst for the highly selective hydrogenation of various α,β-unsaturated aldehydes (e.g., cinnamaldehyde, furfural, crotonaldehyde, and 3-methyl-2-butenal) to the targeted unsaturated alcohols. Highly accessible platinum nanoparticles were sandwiched between a metal-organic framework (MOF) core (i.e., MIL-88B(Fe)) and a MOF shell (i.e., Al-TCPP). In particular, the growth of the Al-TCPP shell was achieved by atomic layer deposition (ALD) of thin-film Al₂O₃ followed by phase transformation with a tetrakis(4-carboxyphenyl)porphyrin (H₄TCPP) linker. The thickness of the Al-TCPP shell can be finely controlled by adjusting the cycle number of alumina ALD and the concentration of the H₄TCPP linker during the phase transformation of Al₂O₃ to Al-TCPP. It was proven that the permeable MOF shells could serve as selectivity regulators for the activation of the CO bonds in α,β-unsaturated aldehydes (in preference to the CC bonds), leading to higher selectivity towards unsaturated alcohols as compared to the conventional surface supported Pt catalysts. Mechanistic insights showed that the enhanced catalytic performance was attributed to (i) the modified electronic state of sandwiched Pt nanoparticles by the two MOF layers and (ii) the steric hindrance effect on substrate diffusion through the sandwich-structured catalysts.

Fabrication of Versatile Hollow Metal-Organic Framework Nanoplatforms for Folate-Targeted and Combined Cancer Imaging and Therapy

Metal-organic frameworks (MOFs) have received extensive attention in the field of biomedicine, particularly serving as multifunctional theranostic nanoplatforms by integrating chemodrugs, imaging agents, and targeting agents. Herein, we report a facile strategy for the fabrication of a hollow and monodisperse MOF (denoted hMIL-88B(Fe)@ZIF-8) consisting of ZIF-8 nanoparticles loaded on the external shell of hollow MIL-88B(Fe). In particular, the hybrid hollow MOF was constructed by partially etching spindlelike MIL-88B(Fe) nanoparticles with 2-methylimidazole in the presence of zinc ions. The obtained hMIL-88B(Fe)@ZIF-8 was then used as a drug/cargo delivery vehicle for loading doxorubicin (DOX), manganese oxide (MnO_x) nanoparticles, and folic acid (FA), forming a multifunctional nanoplatform (denoted hM@ZMDF). Importantly, the resulting hM@ZMDF exhibited a specific targeting property for the FA receptor-overexpressed cancer cells (MCF-7 and HepG-2 cells) and then it unloaded DOX and Fe³⁺ in the tumor microenvironment. Consequently, DOX played dual roles as a chemotherapeutic drug and a fluorescent imaging agent. Also, the released Fe³⁺ could mediate the Fenton reaction and intracellularly generate toxic hydroxyl radicals in the presence of high glutathione in cancer cells. In addition, MnO_x nanoparticles could participate in magnetic resonance imaging. Therefore, the versatile hM@ZMDF nanoplatforms have great potential for smart cancer therapy.